X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
microbiology (213) 213
humans (166) 166
pharmacology & pharmacy (141) 141
infectious diseases (127) 127
index medicus (122) 122
microbial sensitivity tests (118) 118
anti-bacterial agents - pharmacology (104) 104
susceptibility (74) 74
surveillance (51) 51
bacterial infections and mycoses (44) 44
united-states (44) 44
infections (43) 43
resistance (43) 43
biochemical phenomena, metabolism, and nutrition (42) 42
drug resistance, bacterial (40) 40
adult (37) 37
middle aged (37) 37
streptococcus pneumoniae - drug effects (37) 37
antimicrobial resistance (36) 36
female (34) 34
escherichia-coli (32) 32
adolescent (31) 31
aged (31) 31
canada (31) 31
internal medicine (31) 31
male (31) 31
drug resistance (29) 29
infectious and parasitic diseases (29) 29
bacteria (28) 28
united states (27) 27
antibiotics (26) 26
epidemiology (26) 26
pathogens (26) 26
polycyclic compounds (26) 26
enterobacteriaceae (24) 24
anti-bacterial agents - therapeutic use (23) 23
pseudomonas aeruginosa - drug effects (23) 23
canada - epidemiology (22) 22
cephalosporins - pharmacology (22) 22
ciprofloxacin (22) 22
gram-negative bacteria - drug effects (22) 22
prevalence (22) 22
fluoroquinolones (21) 21
gram-negative bacilli (21) 21
hospitals (21) 21
research (21) 21
in-vitro activity (20) 20
streptococcus-pneumoniae (20) 20
child (19) 19
infectious disease (19) 19
anti-infective agents - pharmacology (17) 17
escherichia coli - drug effects (17) 17
infant (17) 17
pseudomonas aeruginosa (17) 17
animals (16) 16
drug resistance, multiple, bacterial (16) 16
gram-negative bacterial infections - microbiology (16) 16
haemophilus influenzae - drug effects (16) 16
immunology (16) 16
medicine & public health (16) 16
pseudomonas-aeruginosa (16) 16
staphylococcus aureus - drug effects (16) 16
urinary tract infections - microbiology (16) 16
child, preschool (15) 15
emergence (15) 15
gram-positive bacteria - drug effects (15) 15
pharmacology/toxicology (15) 15
pharmacotherapy (15) 15
staphylococcus-aureus (15) 15
streptococcus pneumoniae (15) 15
streptococcus pneumoniae - isolation & purification (15) 15
aged, 80 and over (14) 14
cross infection - microbiology (14) 14
infection (14) 14
mortality (14) 14
young adult (14) 14
drug resistance, microbial (13) 13
escherichia coli (13) 13
haemophilus-influenzae (13) 13
klebsiella-pneumoniae (13) 13
levofloxacin (13) 13
molecular epidemiology (13) 13
pneumococcal infections - microbiology (13) 13
respiratory tract infections - microbiology (13) 13
smart (13) 13
staphylococcal infections - microbiology (13) 13
anti-bacterial agents - pharmacokinetics (12) 12
bacteremia (12) 12
escherichia coli infections - microbiology (12) 12
gram-positive bacterial infections - microbiology (12) 12
imipenem (12) 12
infant, newborn (12) 12
population surveillance (12) 12
resistant staphylococcus-aureus (12) 12
strains (12) 12
aminoglycosides (11) 11
analysis (11) 11
antimicrobial susceptibility (11) 11
bacteria - isolation & purification (11) 11
bacteriology (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Microbiology, ISSN 0095-1137, 10/2019, Volume 57, Issue 11
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2019, Volume 69, Issue Supplement_1, pp. S6 - S15
Abstract Omadacycline is a novel aminomethylcycline antimicrobial and semisynthetic derivative of tetracycline. In vitro, omadacycline displays potent activity... 
omadacycline | antimicrobial | INFECTIOUS DISEASES | IN-VITRO | spectrum of activity | pharmacodynamics | tetracyclines | MICROBIOLOGY | PROLIFERATION | IMMUNOLOGY | TOXIN PRODUCTION | Supplement
Journal Article
JOURNAL OF CLINICAL MICROBIOLOGY, ISSN 0095-1137, 11/2019, Volume 57, Issue 11
Journal Article
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, ISSN 0305-7453, 06/2019, Volume 74, Issue 6, pp. 1748 - 1749
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 12/2019
Eravacycline is a novel, fully-synthetic fluorocycline antibiotic developed for the treatment of serious infections, including those caused by... 
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 12/2019
Eravacycline is a novel, fully-synthetic fluorocycline antibiotic being developed for the treatment of serious infections, including those caused by resistant... 
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2018, Volume 63, Issue 1
ABSTRACTThe Clinical and Laboratory Standards Institute (CLSI) broth microdilution method was used to evaluate thein vitroactivities of plazomicin and... 
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2015, Volume 61, p. S58
  Telavancin is a semisynthetic lipoglycopeptide derivative of vancomycin. Telavancin has a dual mechanism of antibacterial action, disrupting peptidoglycan... 
Peptides | Staphylococcus infections | Antimicrobial agents | Drug resistance
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 01/2020, Volume 55, Issue 1, p. 105841
β-lactam- and multi-drug-resistant (MDR) Gram-negative bacilli frequently cause lower respiratory tract infections (LRTIs) in patients housed in intensive care... 
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 10/2019, Volume 6, Issue Supplement_2, pp. S281 - S281
Abstract Background There are limited options available for the treatment of infections caused by Enterobacteriaceae that produce an NDM metallo-β-lactamase.... 
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 08/2019, Volume 94, Issue 4, pp. 321 - 325
In 2017, the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing approved the use of iron-depleted... 
Cation-adjusted Mueller-Hinton broth | Gram-negative bacilli | Iron-depleted | Siderophore | Reproducibility | MIC | Cefiderocol | INFECTIOUS DISEASES | S-649266 | MICROBIOLOGY | VITRO ANTIMICROBIAL ACTIVITY | Moxalactam | Medical colleges | Medical research | Usage | Cephalosporins | Analysis | Communicable diseases | World health | Medicine, Experimental | Cephaloridine | Drug discovery
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 10/2019, Volume 95, Issue 2, pp. 212 - 215
A total of 2732 isolates of collected at 26 United States clinical laboratories in 2015–2017 were tested for susceptibility to imipenem-relebactam.... 
Pseudomonas aeruginosa | Surveillance | SMART | United States | Imipenem-relebactam | Multidrug-resistance | MK-7655 | INFECTIOUS DISEASES | 30-DAY MORTALITY | MICROBIOLOGY | IMPACT | IN-VITRO ACTIVITY | RESPIRATORY-TRACT INFECTIONS | ENTEROBACTERIACEAE
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2019, Volume 53, Issue 4, pp. 456 - 466
Cefiderocol (S-649266) is a parenteral siderophore cephalosporin in phase III of clinical development. In this study, we determined the in vitro susceptibility... 
Gram-negative bacilli | Cefiderocol | global | surveillance | in vitro | siderophore | INFECTIOUS DISEASES | S-649266 | SUSCEPTIBILITY | CEFTAZIDIME-AVIBACTAM | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Moxalactam | Medical colleges | Cephaloridine | Cephalosporins | Medical laboratories
Journal Article
Echocardiography (Mount Kisco, N.Y.), ISSN 0742-2822, 10/2019, Volume 36, Issue 10, pp. 1852 - 1858
The incidence of Staphylococcus aureus infective endocarditis (IE) is steadily rising due to advances in health care delivery. Routine echocardiography is... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.